Vardenafil (Levitra)



5-80 mg /day


  • Concurrent administration with nitrates or donor of nitric oxide (such as amyl nitrite).
  • Co-administration of vardenafil with HIV protease inhibitors (ritonavir, indinavir) is against-indicated because it is potent CYP3A4 inhibitors.
  • Co-administration of vardenafil with potent CYP3A4 inhibitors such as itraconazole, ketoconazole or voriconazole (for systemic use) is against-indicated in patients over 75 years.
  • Severe hepatic impairment (Child-Pugh C).
  • Stade terminal renal failure requiring dialysis.
  • Low blood pressure (RR <90/50 mmHg).
  • Myocardial infarction or stroke within the last 6 months.
  • Unstable angina.
  • Hereditary degenerative retinopathy, such as retinitis pigmentosa.
  • Hypersensitivity to the active substance or to any of the excipients.